Researchers investigated the safety and potential therapeutic efficacy of allogeneic administration of umbilical cord-derived MSCs as a supplementary intervention in combination with standard COPD medication treatments in patients with moderate-to-severe COPD.
[BMJ Open]
6445212
ALUCY3K6
items
1
apa
0
default
asc
1
162343
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/